1997
DOI: 10.1016/s0090-4295(96)00506-7
|View full text |Cite
|
Sign up to set email alerts
|

Improving neuromodulation technique for refractory voiding dysfunctions: Two-stage implant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
115
0
2

Year Published

2003
2003
2013
2013

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 184 publications
(119 citation statements)
references
References 6 publications
2
115
0
2
Order By: Relevance
“…If subjects had 50% improvement in their urinary symptoms, they underwent second stage implantation of the IPG. Using this technique, Janknegt et al [1997] reported satisfactory results in 80% of women previously categorized as having failed PNE, thus qualifying them for IPG implantation. A similar high percentage of patients responding to the FSLP was also reported by Spinelli et al [2003] in a population of patients who had not previously undergone PNE.…”
Section: Introductionmentioning
confidence: 94%
See 2 more Smart Citations
“…If subjects had 50% improvement in their urinary symptoms, they underwent second stage implantation of the IPG. Using this technique, Janknegt et al [1997] reported satisfactory results in 80% of women previously categorized as having failed PNE, thus qualifying them for IPG implantation. A similar high percentage of patients responding to the FSLP was also reported by Spinelli et al [2003] in a population of patients who had not previously undergone PNE.…”
Section: Introductionmentioning
confidence: 94%
“…This was thought to be due to migration of the electrode tip, resulting in a suboptimal test period [Janknegt et al, 1997;Carey et al, 2001]. To circumvent this problem, a two-stage approach for test stimulation was described in 1997.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with conventional test electrode had a median Wexner score of 13.5 (range, [8][9][10][11][12][13][14][15][16] and those with tined lead 15 (range, 6-20); p=0.553. All patients received single dose antibiotics preoperatively (1000 mg cefazolin and 500 mg metronidazole intravenously).…”
Section: Methodsmentioning
confidence: 99%
“…Due to a high migration rate of test electrodes and due to the invasiveness of open implantation of the permanent system [8], Spinelli et al [9], and the manufacture of the stimulator (Medtronic, Minneapolis, USA) recently developed a transcutaneous electrode (tined lead electrode) and a minimally invasive introducing kit. The new transcutaneous system is designed as a permanent electrode and can be used for both screening and permanent stimulation.…”
Section: Introductionmentioning
confidence: 99%